KavitaRajDO

Family Medicine • Marion, IN

Physician

Join to view full profile

Dr. Raj is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Raj's full profile

Already have an account?

Office
1399 N Baldwin Ave
Marion, IN 46952
Phone+1 765-660-7550

Fax+1 765-662-4467

Education & Training

University of Illinois College of Medicine at ChicagoResidency, Family Medicine, 1995 - 1997
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1994

Certifications & Licensure

IN State License 1997 - 2025
IL State License 1995 - 1999
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

42 citations
Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study.
Aytug Kizilors, Elena Crisà, Nicholas Lea, Roberto Passera, Syed A Mian
The Lancet. Haematology. 2019-05-01
44 citations
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow T...
Kavita Raj, Diderik Jan Eikema, Donal P. McLornan, Eduardo Olavarria, Henric Jan Blok
Biology of Blood and Marrow Transplantation. 2019-03-01
6 citations
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning.
Marie Robin, Kavita Raj, Sylvie Chevret, Jordan Gauthier, Hugues de Lavallade
European Journal of Haematology. 2018-10-01

Press Mentions

Comparative Analysis of Melphalan Versus Busulphan T‐Cell Deplete Conditioning Using Alemtuzumab in Unrelated Donor Stem Cell Transplantation for Acute Myeloid LeukaemiaAugust 8th, 2019